Cytek BioSciences, Inc. (CTKB) Social Stream
Cytek Biosciences Inc (CTKB) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering CTKB.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 14 days, CTKB's average price target has gone down $1.5.
Over the past 26 weeks, CTKB's average upside potential has been 20.05%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
CTKB Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
CTKB's average broker recommendation rating improved by 0 over the prior 31 days.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of all US stocks, Cytek Biosciences Inc's number of analysts covering the stock is higher than 38.14% of them.
- Cytek Biosciences Inc's variance in analysts' estimates is lower than 54.99% of Healthcare stocks.
- Cytek Biosciences Inc's average analyst price target is greater than 56.77% of Measuring and Control Equipment stocks.
- CTKB has a higher upside potential (average analyst target price relative to current price) than 311.53% of Measuring and Control Equipment stocks.
What is the outlook for CTKB? Use POWR Ratings for clearer insight into price direction.